The fund is rated 4 stars. Considered together, the fund's movement relative to its index and annual fee of 1.19% place it ahead of most similar funds.
This index fund/ETF has a beta of 0.937%, and an expense ratio of 1.19%, giving it a 4.0 star rating, based on the principle that lower values of |1-beta| and expense ratio result in higher ratings.
અમારો સ્કોર લાંબા ગાળાની કામગીરી, જોખમ અને સાતત્યને વજન આપે છે — ફક્ત ભૂતકાળના વળતરને નહીં.
રિટર્ન
24 Sep 2026 મુજબ
જોખમ ગુણોત્તર
31 Aug 2026 મુજબ
ફંડ વિગતો
Long term wealth creation solution. An index fund that seeks to track returns by investing in a basket of Nifty Pharma Index stocks and aims to achieve returns of the stated index, subject to tracking error.
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
